[Expression of tumor-specific cancer/testis antigens in hepatocellular carcinoma].

Hongsong Chen(Inner Mongolia University for Nationalities), Lai Wei(Tongji University), Xu Cong(Dali University), Yu Wang(The Ohio State University Wexner Medical Center), Weifeng Chen(Peking University), Ran Fei(Peking University), Ji Cao(Tumor Hospital of Guangxi Medical University), Dong Jiang(Second Military Medical University), Liu-liang Qin, Jianjia Su(Tumor Hospital of Guangxi Medical University)
PubMed
March 1, 2003
Cited by 13

Related Papers

New progress in the pharmacology of protocatechuic acid: A compound ingested in daily foods and herbs frequently and heavily
|Pharmacological Research|2020|301
Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2015|271
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122
The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease
|Journal of Hepatology|2021|118
STING expression in monocyte-derived macrophages is associated with the progression of liver inflammation and fibrosis in patients with nonalcoholic fatty liver disease
|Laboratory Investigation|2019|109